Clinical Trial Update: A Study of HLX42 in Advanced/Metastatic Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating HLX42 in advanced/metastatic solid tumors, including non-small cell lung cancer, is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• HLX42

Snippet

Sponsor: Shanghai Henlius Biotech | Conditions: Solid Tumor and NSCLC | Phase 1 | Status: RECRUITING